Imatero-400

Imatero-400 Indications/Uses

imatinib

Manufacturer:

Camber

Distributor:

Camber
Full Prescribing Info
Indications/Uses
Acute lymphoblastic leukemia: Adults with relapsed or refractory Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL).
Aggressive systemic mastocytosis: Adults with aggressive systemic mastocytosis without the D816V c-Kit mutation or with c-Kit mutational status unknown.
Dermatofibrosarcoma protuberans: Adults with unresectable, recurrent, and/or metastatic dermatofibrosarcoma protuberans.
GI stromal tumors: Patients with Kit (CD117)-positive unresectable and/or metastatic malignant GI stromal tumors; adjuvant treatment of adults following complete gross resection of Kit (CD117)-positive GI stromal tumors.
Hypereosinophilic syndrome and/or chronic eosinophilic leukemia: Adults with hypereosinophilic syndrome and/or chronic eosinophilic leukemia who have the FIP1L1-platelet-derived growth factor (PDGF) receptor alpha fusion kinase (mutational analysis or fluorescent in situ hybridization [FISH] demonstration of CHIC2 allele deletion) and for patients with hypereosinophilic syndrome and/or chronic eosinophilic leukemia who are FIP1L1-PDGF receptor alpha fusion kinase negative or unknown.
Myelodysplastic/Myeloproliferative diseases: Adults with myelodysplastic/ myeloproliferative diseases associated with PDGF receptor gene rearrangements.
Newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia: Newly diagnosed adults and pediatric patients with Ph+ chronic myeloid leukemia (CML) in chronic phase.
Philadelphia chromosome-positive chronic myeloid leukemia in blast crisis, accelerated phase, or chronic phase after interferon-alpha therapy: Patients with Ph+ chronic myeloid leukemia (CML) in blast crisis, accelerated phase, or in chronic phase after failure of interferon-alpha therapy.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in